Alpfa Medical
Initial Transaction Details
Transaction Date
December 2024
Purpose of Financing
Venture
Stage of Company
Early Stage
Structure of Financing
Equity
Alpfa Medical develops minimally invasive pulsed field ablation (PFA) systems to treat soft tissue conditions, with a major focus on benign prostatic hyperplasia (BPH).
Website